Pharmaceutical

Opinion: Neuroscience has to grapple with a long legacy...

Neuroscience and its related fields have long discriminated against Black people...

Opinion: Listen: What we take for granted after 30 year...

"If you were going to be depressed any time in history and were interested in ha...

STAT+: Blood cancers may arise from CAR-T cells, but ex...

“I don’t think it changes the risk-benefit calculation for any particular patien...

STAT+: Colon cancer prevention paradox: Higher-risk pat...

Patients at risk for colorectal cancer “are literally being penalized” with high...

Tanden, Becerra, Califf make time for a meeting with to...

A host of major Biden health officials took time for a meeting with tobacco indu...

STAT+: White House official dings Bristol Myers Squibb ...

A White House Domestic Policy Council deputy criticized Bristol Myers Squibb's e...

STAT+: Scott Gottlieb, Trump FDA chief, questions wheth...

One of the GOP's most prominent health care thinkers, former FDA Commissioner Sc...

More colonoscopy news and research

A study questioned colonoscopies as the gold standard of colon cancer screens. T...

Novovax’s Omicron-targeting Covid-19 vaccine obtains WH...

Novovax has been granted emergency use listing (EUL) by the World Health Organi...

Boehringer to leverage IBM’s technologies for antibody ...

Boehringer Ingelheim has entered an agreement with IBM to leverage the latter’s...

Abeona’s cell therapy secures priority approval date fo...

Abeona Therapeutics’s pz-cel (prademagene zamikeracel) has received a US Fo...

FDA accepts Orexo’s NDA for opioid overdose medication

The US Food and Drug Administration (FDA) has accepted Orexo’s new drug applica...

Radiopharmaceuticals reach record high with $408m in ve...

Venture financing for innovative radiopharmaceutical drugs witnessed an approxi...

FDA rejects Aldeyra’s dry eye drug, asks for more clini...

The US Food and Drug Administration (FDA) has issued a complete response letter...

Acelyrin claims errors by CRO Fortrea led to late-stage...

Immunology biotech Acelyrin has determined that its CRO partner Fortrea is resp...

Bayer’s stock drops to new 18-year low after asundexian...

Bayer’s stock price has plummeted to its lowest since 2005 after a clinical tri...